Overview

• The U.S. Supreme Court is reviewing a Tennessee law that prohibits puberty blockers, cross-sex hormones, and surgeries for minors with gender dysphoria.
• The Biden administration and the ACLU argue the law violates equal protection rights, while the state defends it as necessary for child safety.
• Critics of these treatments point to weak scientific evidence and concerns raised by European countries that have restricted their use for minors after reassessing risks and benefits.
• A Washington Post editorial emphasized the lack of large, rigorous studies on the effectiveness and safety of puberty blockers and called for better research to guide policy decisions.
• The Court's decision, expected in mid-2025, could set a significant precedent for state-level restrictions on gender-affirming care across the U.S.